What the work can inform
Compare clinical outcomes, costs and resource use with explicit assumptions, perspective and uncertainty. Findings support deliberation by clinicians, institutions and decision-makers.
HEALTH ECONOMICS · DECISION SCIENCE
Make health investment decisions explicit, testable and informed by evidence.
We develop economic evaluations and decision frameworks that connect clinical outcomes, resource use, costs and uncertainty. Work can inform treatment choices, service design and health-system investment. Methods, perspective, comparators, time horizon and data limitations are stated so clinicians, governments, institutions and funders can understand the trade-offs. Models support transparent deliberation; they do not replace clinical or public judgment.
THE QUESTION · THE USE · THE STATUS
Compare clinical outcomes, costs and resource use with explicit assumptions, perspective and uncertainty. Findings support deliberation by clinicians, institutions and decision-makers.
Published outputs and work under review are identified in Evidence. Results depend on the population, comparators, data and decision threshold; they cannot be transferred unchanged between countries.
Each project must define accountable investigators, data sources and date, methods, limitations, applicable approvals and contributions. Funding and membership do not determine findings. Scientific governance →
Members and external applicants may apply to ICU, ROP and pediatric cancer capacity-mapping projects. Membership is not required for these mapping calls; each brief retains its residence, language and scientific requirements.
Selection and onboarding are subject to eligibility, available places and project-specific permissions. These dates do not authorize clinical work.
SCOPE · INPUTS · USE
These pathways guide a scientific conversation. Outputs, resources, permissions and timing are agreed per project; they are not a contractual offer or results already delivered.
OUR SCIENTIFIC AGENDA
Cost-effectiveness and cost-utility analyses with explicit comparators, perspective and time horizons.
Frameworks for willingness-to-pay calibration and net monetary benefit across settings.
Probabilistic analysis, ICER stability and NMB/INMB to examine decision robustness.
Protocols, participating institutions, roles, data rights, IP and economic arrangements are documented for each project and may require negotiation with investigators and stakeholders.
Review the scientific collaboration framework →EVIDENCE & OUTPUTS
This methodological study evaluates the empirical stability of the incremental cost-effectiveness ratio relative to net monetary benefit under probabilistic uncertainty, examining which metric communicates decision uncertainty more reliably.
No public preprint or journal article is linked in the verified register.
PORTFOLIO & OPEN CALL
Each project retains its status, requirements, dates and approval process. An open call does not establish patient recruitment, funding or permissions. Review the project brief before applying.
1 / 1 matching projects
Reproduce, critically evaluate and extend country-specific health economic decision thresholds and monetary net-benefit methods for global health-system decision making. The project will test sensitivity to alternative health-expenditure definitions, life-expectancy modelling choices, temporal updating, macroeconomic assumptions and uncertainty; outputs will emphasize transparent limitations and appropriate use in resource-allocation decisions.
Reproduce, critically evaluate and extend country-specific health economic decision thresholds and monetary net-benefit methods for global health-system decision making. The project will test sensitivity to alternative health-expenditure definitions, life-expectancy modelling choices, temporal updating, macroeconomic assumptions and uncertainty; outputs will emphasize transparent limitations and appropriate use in resource-allocation decisions.
Choose your active membership category.
Students & Young ProfessionalsClinicians & InvestigatorsONE NETWORK · SHARED SCIENTIFIC CAPACITY
Observatory participation connects clinical and methodological expertise with research execution, collaboration and health-system questions. The membership pathway is Clinicians & Investigators, with the same benefits and conditions across observatories.
There is no additional Observatory subscription. Membership supports shared staff, infrastructure, approved publication support and community programs. Scientific admission and individual project approval remain separate decisions.
Propose reviews, original studies, case reports or innovation projects. Staffing, publication support, timelines and costs are agreed within the membership terms and a project-specific plan.
An approved, documented Observatory role may support the corresponding microscopIA affiliation for eligible work. Membership alone does not authorize institutional representation, endorsement or unrestricted use of the name.
Propose a hosted group with a research program, leader CV and at least three projects. Scientific fit, supervision, resources and a recruitment plan must be approved before launch.
Explore hosted groups →Provide your CV, expertise, availability, conflicts of interest and a proposed contribution. Keep patient information out of the application.
microscopIA reviews scientific fit and confirms responsibilities, project supervision and required permissions. We aim to communicate a decision or request for information within 10 calendar days.
Execution begins after written scientific approval, an agreed resource allocation and any required ethics, data or institutional authorization.
Authorship follows substantive contributions, manuscript review, final approval and accountability. Payment does not secure authorship, first-author position, editorial acceptance, data access or a role in a particular project.
Membership conditions → · Scientific collaboration framework →
FOR CLINICIANS & SCIENTIFIC COLLABORATORS
Bring clinical context to economic models: relevant comparators, care pathways, resource use and outcomes that matter to patients.
Define meaningful questions, outcomes and interpretation.
Discuss this contribution →Discuss local service mapping, feasibility and institutional coordination.
Discuss this contribution →Contribute to evidence appraisal, modelling or decision briefs.
Discuss this contribution →WORK WITH THE PROGRAM
Explore collaboration, project participation and responsible funding through the program’s existing pathways.
PHILANTHROPY & PARTNERSHIP
Individuals, families, institutions and funders can make a one-time contribution or discuss recurring support. Contributions are separate from membership and preserve scientific independence.
microscopIA hosts the scientific environment and manages contracts, resources and institutional appointments.
Appointed scientific leads develop focused programs and supervise approved work.
Steering committees connect groups and experts to review priorities, proposals, conflicts and progress.
Named principal investigators remain accountable for study protocols, permissions, methods and contributions.
Committee seats and delegated authority require formal appointment. microscopIA coordinates intake and appoints competent reviewers before execution. Membership does not confer authority to represent or contract for the organization.
Collaboration and governance →Every new research project, case report, case series or innovation proposal requires written approval from the Observatory steering committee under microscopIA governance or appointed research group scientific lead. Admission or membership does not replace this approval.
microscopIA appoints competent reviewers before execution. Reviewers disclose conflicts and recuse themselves where appropriate. Membership does not confer contracting authority or permission to reuse contacts or data for external projects.
Protocols and collaboration agreements